Lerner Lorena Raquel
SEC insider (Form 3/4/5 filer). CIK 0002081359. Chief Scientific Officer at Keros Therapeutics, Inc. (KROS). 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in LEXINGTON, MA.
Companies Lerner Lorena Raquel has filed insider reports for
- Keros Therapeutics, Inc. (KROS): Officer, Chief Scientific Officer
Lerner Lorena Raquel
CIK: 0002081359
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (66.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KROS
Keros Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Aug 18, 2026KROS
Keros Therapeutics, Inc.
SaleDirect3.6K shares at avg. $10.29$37K - Feb 24, 2026KROS
Keros Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
75K shares- - Feb 18, 2026KROS
Keros Therapeutics, Inc.
SaleDirect3.9K shares at avg. $16.35$63K
1-3 of 3 transactions